The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury

Ugo Soffientini (1, 2) , Nigel Beaton (1) , Sukriti Baweja (3) , Emmanuel Weiss (4, 5) , Chhagan Bihari (3) , Abeba Habtesion (1) , Vishal Patel (2, 6, 7, 8) , Valerie Paradis (4) , Archana Sharma (3) , Tu Vinh Luong (1) , Andrew Hall (1) , Aida Nadar (1) , Shiv Sarin (3) , Shilpa Chokshi (2) , Roger Williams (2) , Benedicte Py (9) , Richard Moreau (4) , Rajiv Jalan (1) , Gautam Mehta (2, 1)

1 UCL - University College of London [London]
2 Foundation for Liver Research
3 Institute of Liver and Biliary Sciences [New Delhi]
4 Hôpital Beaujon [AP-HP]
5 CRI (UMR_S_1149 / ERL_8252 / U1149) - Centre de recherche sur l'Inflammation
6 King‘s College London
7 KCH - King's College Hospital
8 NHS Foundation Trust [London]
9 CIRI - Centre International de Recherche en Infectiologie

Background and aims: The development of multi-organ injury in cirrhosis is associated with increased intestinal permeability, translocation of gut-derived bacterial products [e.g., lipopolysaccharide (LPS)] into the circulation, and increased non-apoptotic hepatocyte cell death. Pyroptosis is a non-apoptotic, lytic form of cell death mediated by the LPS-sensing caspase(s)-4/11 (caspase-4 in humans, caspase-11 in mice), which leads to activation of the effector protein Gasdermin D (GSDMD) and subsequent formation of pores in the plasma membrane. Endoplasmic reticulum (ER) stress, a feature of cirrhosis, has been identified as a factor promoting the activation of caspase-11, thus increasing sensitivity of the cell to LPS-mediated pyroptosis. The aim of this study was to determine the role of bacterial LPS in the activation of hepatic caspase(s)-4/11 and progression of hepatic and extra-hepatic organ injury in cirrhosis. Materials and methods: Human liver samples from patients with stable cirrhosis (SC) or acutely decompensated cirrhosis (AD) were analyzed for caspase-4 activation by immunohistochemistry. Wild-type and Casp11 -/- mice underwent CCl4 treatment by gavage to induce advanced liver fibrosis, and subsequently low-dose injection of LPS to mimic bacterial translocation and induce multi-organ injury. Liver, kidney, and brain function were assessed by plasma ALT/creatinine and brain water respectively. The activity of inflammatory caspases was assessed by fluorometric assay and the occurrence of pyroptosis and overall cell death in liver tissue by GSDMD cleavage and TUNEL assay, respectively. Primary human hepatocytes were cultured according to standard techniques. Results: Human liver samples demonstrated increased caspase-4 activation in AD cirrhosis. Caspase-4 activation was associated with MELD score and circulating levels of LDH. Wild-type mice treated with CCl4 developed significant multi-organ injury (increased ALT, creatinine, and brain water) upon LPS injection, and showed increased hepatic GSDMD cleavage compared to mice treated with CCl4 alone. Primary human hepatocytes could be sensitized to pyroptosis by pre-treatment with the ER-stress inducer tunicamycin and LPS. Casp11 -/- mice treated with CCl4 + LPS were significantly protected from multi-organ injury compared to wild-type CCl4 + LPS. Conclusion: These data demonstrate for the first time a causal relationship between LPS-mediated activation of caspase(s)-4/11 and development of hepatic and extra-hepatic injury in cirrhosis.

Mots clés: caspase; cirrhosis; dysbiosis; endotoxin; lipopolysaccharide; liver failure; pyroptosis.

Domaines: Sciences du Vivant [q-bio]; Immunologie

Ugo Soffientini, Nigel Beaton, Sukriti Baweja, Emmanuel Weiss, Chhagan Bihari, et al.. The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury. Frontiers in Cell and Developmental Biology, 2021, 9, pp.668459. ⟨10.3389/fcell.2021.668459⟩. ⟨inserm-03906809⟩